Dake Benjamin T

CIK 00018692481 companyBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001869248

Recent Transactions

50 trades

Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2024-08-01$1.74/sh+1,507→ 14,252 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-08-01−1,507→ 0 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2024-07-31$1.74/sh+11,454→ 12,745 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-07-31−10,548→ 1,507 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-07-31−906→ 0 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-04-17$22.32/sh−6,447→ 1,697 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-04-17−6,853→ 95,936 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2024-04-17$2.14/sh+6,853→ 8,144 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-04-17$23.97/sh−68→ 1,291 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-04-17$23.17/sh−338→ 1,359 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-04-01$31.97/sh−3,325→ 1,291 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-04-01−3,325→ 25,675 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2024-04-01$10.61/sh+3,325→ 4,616 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-03-27−11,068→ 29,000 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2024-03-27$10.61/sh+11,068→ 12,359 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-03-27$27.97/sh−11,068→ 1,291 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2024-03-25$10.61/sh+3,432→ 4,723 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-03-25$28.01/sh−3,432→ 1,291 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-03-25−3,432→ 40,068 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2024-03-18$10.61/sh+14,500→ 36,348 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-03-18$25.74/sh−27,476→ 8,872 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-03-18−14,500→ 43,500 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2024-03-18$26.48/sh−7,581→ 1,291 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2024-03-18$2.14/sh+20,557→ 21,848 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-03-18−20,557→ 102,789 total
Award
Jade Biosciences, Inc.$JBIO
Stock Options (Right to Buy)
2024-01-22+66,586→ 66,586 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-12-06−1,019→ 16,294 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2023-12-06$16.11/sh−10,283→ 1,291 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2023-12-06$1.74/sh+2,411→ 3,702 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-12-06−6,853→ 123,346 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2023-12-06$2.14/sh+7,872→ 11,574 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-12-06−905→ 906 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-12-06−1,506→ 12,055 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2023-11-27$2.14/sh+10,104→ 13,808 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2023-11-27$16.24/sh−12,517→ 1,291 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-11-27−906→ 1,811 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-11-27−1,507→ 13,561 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-11-27−1,018→ 17,313 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2023-11-27$1.74/sh+2,413→ 3,704 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-11-27−9,086→ 130,199 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2023-11-24$16.07/sh−70→ 1,291 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-11-24−371→ 18,331 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2023-11-24$2.14/sh+4,990→ 6,281 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-11-24−4,619→ 139,285 total
Sale
Jade Biosciences, Inc.$JBIO
Common Stock
2023-11-24$15.74/sh−4,920→ 1,361 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-11-22−6,322→ 143,904 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-11-22−1,507→ 15,068 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-11-22−905→ 2,717 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Common Stock
2023-11-22$1.74/sh+2,412→ 3,703 total
Exercise/Conversion
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-11-22−648→ 18,702 total

Companies

Jade Biosciences, Inc.
See Remarks
$JBIO

Recent Filings

Address

C/O AEROVATE THERAPEUTICS, INC. 200 BERKELEY STREET, FLOOR 18

BOSTON, MA, 02116

View on SEC.gov